Skip to search formSkip to main contentSkip to account menu

SKLB 010

Known as: SKLB-010, SKLB010 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Synthesis and evaluation of novel thiazole‐based derivatives as selective inhibitors of DNA‐binding domain of the androgen receptor
A series of thiazole‐based inhibitors selectively targeting DNA‐binding domain of the androgen receptor (AR) were synthesized and… 
2018
2018
Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals
ABSTRACT Tuberculosis is a major global health problem, and the emergence of multidrug-resistant and extensively drug-resistant… 
2017
2017
A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine models.
2012
2012
(Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione protects rats from carbon tetrachloride-induced liver injury and fibrogenesis.
AIM To evaluate the hepatoprotective roles of (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione (SKLB010) against carbon… 
2011
2011
Effect of SKLB010 on albuminuria and monocytes chemotactic protein-1 expression in MRL/lpr mice
OBJECTIVE To investigate the therapeutic effect of SKLB010 on inflammatory cell infiltration and monocytes chemotactic protein-1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)